UNITED THERAPEUTICS

UNITUXIN

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

UNITED THERAPEUTICS

Unituxin HCPCS:

J1246

HCPCS Code Descriptor:

Injection, dinutuximab, 0.1 mg

Category:

J Code

Unituxin NDCs:

66302-0014-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Not Found

Route of Administration:

Intravenous

Unituxin CPT Codes:

Potential CPT administration codes for Unituxin can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Unituxin:

UNITUXIN is a Oncology drug manufactured by UNITED THERAPEUTICS and administered via the Intravenous route of administration. The J Code: J1246 is aligned to the drug UNITUXIN.

Unituxin is an injectable medication used to treat neuroblastoma in children. Neuroblastoma is a rare type of cancer of the nervous system. Unituxin is an immunotherapy drug, typically given as a second-line treatment after the patient has had positive responses to other forms of treatment.

ACCESS PRICING AND MORE BY REGISTERING

J1246 Added Date:

January 1, 2024

J1246 Effective Date:

January 1, 2024

J1246 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Unituxin billing and coding information.
Our team did not identify a source for Unituxin patient assistance information. Please reach out to our team if you feel that this is a mistake.
UNITUXIN prescribing information can be found at the link below:
Information regarding UNITUXIN’s side effects can be found at MedlinePlus